Revvity, ES-363-CF, cAMPZen Frozen Human Vasopressin V2 Cell Line, 1321N1 Cells

Overview
Vasopressin V2 cAMPZen cells are validated frozen cells designed for high-throughput screening to identify drug candidates targeting the human Vasopressin V2 receptor expressed in 1321N1 host cells. The cAMPZen technology enables researchers to easily detect changes in cAMP levels as a direct indicator of receptor activation, making it valuable for tool for drug discovery. Each vial contains 2.5 million frozen cells validated for cAMP testing, providing a consistent and ready-to-use supply that streamlines workflows and accelerates drug discovery. The frozen format ensures reliable performance while maintaining cell viability. Please note that these cells are authorized for single-use only, and transfer, re-use, or propagation is not permitted under the product terms and conditions. Application-cAMP Drug Discovery & Development
Brand-cAMPZen
G-Alpha Natural Receptor-G s
Host Cell Line-1321N1
Host Species-Human
One Unit Contains-1 vial(s)
Product Group-Cell Line
Receptor-Vasopressin
Second Messenger Release-cAMP
Shipping Conditions-Shipped in Dry Ice
Target Class-GPCR
Therapeutic Area-Cardiovascular
Unit Size-2.5 million cells
Validation-cAMP Downstream Phosphorylation